UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 12, 2014

 

REVOLUTIONS MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-28629

 

73-1526138

(State or other jurisdiction

of incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

  

1124 Park West Blvd. Suite #102

Mount Pleasant, SC 29466

  

  

(Address of Principal Executive Offices)

  

 

(843) 971-4848

Registrant’s telephone number, including area code
  

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 5.03.

Amendments to Articles of Incorporation or Bylaws

 

On December 12, 2014, Revolutions Medical Corporation (the “Company”) filed an amendment to its Certificate of Incorporation (the “Amendment”) to increase its authorized capital stock from 250,000,000 shares to 755,000,000 shares, consisting of 750,000,000 shares of common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share. A copy of the Amendment is attached as Exhibit 3.1 hereto and incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.


 

Exhibit

Number

 

 

Description

 

3.1

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Revolutions Medical Corporation.

 

 
 

 

 

SIGNATURE

 

            Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

REVOLUTIONS MEDICAL CORPORATION

 

 

 

 

Date: January 5, 2014

By:

/s/ Rondald L. Wheet                                         

 

 

 

Rondald L. Wheet

 

 

 

Chief Executive Officer

 

 



Exhibit 3.1